Eric Venker
President & Immunovant CEO at Roivant Sciences; Chief Executive Officer at Immunovant.
- Rank
- 3017th of 14,644
- Companies held
- 2
- Largest holding
- ROIV, 79.1% of total
- Latest SEC filing
- Nov 10, 2026
What the $40.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Roivant Sciences ROIV Common Shares | Directly | 811,211 | $39.06 | $31.7M | 79.1% | Form 4, Nov 10, 2026 |
| Immunovant IMVT Common Stock | Directly | 257,075 | $32.48 | $8.3M | 20.9% | Form 4, Oct 2, 2026 |
Share counts are the amounts Eric Venker reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Sold | ROIV | 158,194 | $40.44 | $6.4M | View |
| Nov 10, 2026 | Sold | ROIV | 29,749 | $41.00 | $1.2M | View |
| Nov 3, 2026 | Sold | ROIV | 200,000 | $36.31 | $7.3M | View |
| Oct 28, 2026 | Sold | ROIV | 200,000 | $36.59 | $7.3M | View |
| Oct 20, 2026 | Sold | ROIV | 185,856 | $35.09 | $6.5M | View |
| Oct 20, 2026 | Sold | ROIV | 14,144 | $35.42 | $501K | View |
| Oct 2, 2026 | Sold | IMVT | 3,506 | $34.11 | $120K | View |
| Sep 30, 2026 | Sold | ROIV | 200,000 | $36.62 | $7.3M | View |
| Aug 28, 2026 | Sold | ROIV | 166,182 | $35.63 | $5.9M | View |
| Aug 28, 2026 | Sold | ROIV | 33,818 | $36.44 | $1.2M | View |
| Jul 27, 2026 | Sold | ROIV | 200,000 | $34.95 | $7.0M | View |
| Jul 2, 2026 | Sold | IMVT | 3,092 | $38.48 | $119K | View |
| Jun 24, 2026 | Sold | ROIV | 46,234 | $33.51 | $1.5M | View |
| Jun 24, 2026 | Sold | ROIV | 153,766 | $33.05 | $5.1M | View |
| May 22, 2026 | Sold | ROIV | 200,000 | $30.27 | $6.1M | View |
| Apr 20, 2026 | Sold | ROIV | 200,000 | $29.59 | $5.9M | View |
| Apr 2, 2026 | Sold | IMVT | 1,409 | $24.60 | $35K | View |
| Apr 2, 2026 | Sold | IMVT | 12,820 | $24.04 | $308K | View |
| Mar 17, 2026 | Sold | ROIV | 200,000 | $28.24 | $5.6M | View |
| Feb 13, 2026 | Sold | ROIV | 200,000 | $26.49 | $5.3M | View |
| Jan 12, 2026 | Sold | ROIV | 200,000 | $21.92 | $4.4M | View |
| Dec 24, 2025 | Sold | ROIV | 75,000 | $22.53 | $1.7M | View |
| Dec 23, 2025 | Sold | ROIV | 200,000 | $22.45 | $4.5M | View |
| Dec 9, 2025 | Sold | ROIV | 200,000 | $20.85 | $4.2M | View |
| Nov 7, 2025 | Sold | ROIV | 200,000 | $20.22 | $4.0M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3014 | Mary P. DePrey Director, Schneider National. Green Bay, WI | $40.1M |
| 3015 | David H. Hoster II Director, EastGroup Properties. Ridgeland, MS | $40.1M |
| 3016 | James J. Kavanaugh Sr. VP and CFO, International Business Machines. Bellevue, WA | $40.1M |
| 3017 | Eric Venker President & Immunovant CEO, Roivant Sciences | $40.0M |
| 3018 | Thomas A. Martin President, Kinder Morgan. Houston, TX | $40.0M |
| 3019 | David Joseph Meyer Chairman, Titan Machinery. West Fargo, ND | $40.0M |
| 3020 | Marc S. Pritchard Chief Brand Officer, The Procter & Gamble. Cincinnati, OH | $40.0M |
Other Roivant Sciences insiders
All ROIV insiders- Dan Oren$4.02B10% owner. #77 overall
- Vivek Ramaswamy$1.84B10% owner. #154 overall
- Daniel Allen Gold$727MDirector. #279 overall
- Mayukh Sukhatme$719MPresident & CIO. #350 overall
- Matthew Gline$640MCEO. #333 overall
- Frank Torti$481MPresident and Vant Chair. #475 overall
Questions
How much stock does Eric Venker own?
Eric Venker holds $40,035,698 in listed stock based on SEC filings and current prices, mostly Roivant Sciences (ROIV). That ranks 3017th on the Stock Rich List.
Is this Eric Venker's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Eric Venker last buy or sell stock?
The most recent open-market trade on file is a sale of 158,194 ROIV shares on Nov 10, 2026 at $40.44.